Medicine shortages will result if drug prices are driven too low | Pharmaceuticals industry
Key takeaway
OHE warns unsustainably low off-patent medicine prices push generic manufacturers to exit, leaving too few suppliers.
- Step 1 · The triggerunsustainably low off-patent medicine prices erode manufacturer margins, causing generic and biosimilar manufacturers to exit the UK market
- Step 2 · Knock-onmanufacturer exits reduce the number of suppliers, leaving NHS medicine markets concentrated and vulnerable to shortages
- Step 3 · Knock-onBrexit's loss of access to EU medicine reserves removes a key buffer, so shortages can no longer be buffered by shared European stockpiles
- Step 4 · Reaches youUK SMEs in pharmacy, care homes, and healthcare logistics face supply disruptions and cost increases as generic medicine availability tightens
The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.
Source: theguardian.com
See what today’s news does to your business. Atri by Branch² — Early-warning intelligence for your businessThis is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.